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The most recent World AIDS Day serves as a timely reminder that an HIV-1 vaccine remains a major 
goal in biomedical science. Macaque models of HIV-1 infection have been instrumental in pre-
clinical and passive immunization studies. However, due to species-specific barriers, HIV-1 cannot 
establish a long-term infection in macaque cells. Therefore, modeling HIV-1 infection in macaques 
often requires use of chimeric SIV (simian immunodeficiency virus)/ HIV viruses (SHIVs). Chimeric 
SHIVs require adaptation to persistently infect macaques, presumably due to differences between 
macaque CD4 (mCD4) and human CD4, the receptor for HIV-1. The envelope glycoprotein of HIV-1 
(Env) is the major target of the host immune response and is the focus of most vaccine development 
strategies. Previous studies had isolated two independent Env mutations (A204E and G312V) that 
enabled a 100-fold increase in CD4-mediated entry into macaque cells. However, the consequences 
of adaptation to a macaque host for the antigenic properties of Env had remained unaddressed. This 
is important because if the SHIV Env would not faithfully recapitulate the immunological properties of 
Env from circulating HIV-1 subtypes infecting humans, their use as models for vaccine development 
could be limited. This question was recently addressed by a Fred Hutch study published in 
the Journal of Virology, and led by graduate student David Boyd in the lab of Dr. Julie Overbaugh 
(Human Biology and Public Health Sciences Divisions). 
As a first test to determine to what extent, if any, the antigenic properties of Env changed during 
adaptation, the authors introduced the A204E and G312V mutations either alone, or in combination, 
into Env proteins derived from representative sub-Saharan African HIV-1 subtypes. While 
introduction of both mutations simultaneously resulted in non-functional Envs, five out of seven Envs 
permitted mCD4-mediated infection with either A204E or G312V, whereas for the remaining two, 
only the A204E mutation enabled mCD4-dependent entry. These A204E or G312V-containing Envs 
that could replicate in a CD4-dependent manner are hereafter collectively referred to as mCD4-
adapted Envs. The Env protein exists as trimer, and engagement by CD4 results in a more open 
conformation (see figure). The researchers hypothesized that mCD4-adapted Envs exhibited a 
similarly open conformation, which would render them more sensitive to antibodies specific for 
antigens that are not accessible in the closed conformation. To test this hypothesis, the researchers 
used a panel of neutralizing antibodies that recognize either quaternary epitopes (PG9, PG16, 
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PGT145, VRC03; only present in closed conformation trimer) or CD4-induced epitopes (sCD4, 17b; 
exposed in the open conformation). Strikingly, the authors found that a subset of mCD4-adapted 
Envs became resistant to neutralization by antibodies that target quaternary epitopes while 
becoming sensitive to CD4-induced epitopes. "Our results suggest that there are antigenic 
consequences of adapting HIV-1 envelope to the macaque CD4 receptor and help explain why it has 
been so difficult to generate challenge viruses that are representative of HIV-1 variants circulating in 
people," said Mr. Boyd. 
Next, the investigators assessed the neutralization profiles of Envs derived from either pathogenic 
SHIVs or CD4-independent strains of HIV-1. Notably, both types exhibited neutralization profiles 
similar to that of mCD4-adapted Envs, suggesting that comparable conformational changes 
accompany CD4-independence and adaptation to mCD4. Finally, the researchers determined if the 
ability to use mCD4 as a receptor could predict the neutralization profile of Envs. To this end, the 
authors compared the ability of Envs isolated from 48 recently transmitted variants to infect cells 
expressing either mCD4 or human CD4, yet found that the ability to use mCD4 is not a determinant 
of sensitivity to the quaternary PG9/PG16 antibodies. Overall, this study demonstrated that 
adaptation of HIV-1 to mCD4 results in significant structural and functional changes in Env, and 
informs the design of future SHIV models. 
"We did identify a subset of HIV-1 envelopes that are able to use macaque CD4 for entry and 
maintain key antigenic properties of transmitted viruses. We are now interested in developing novel 
challenge viruses based on these envelopes", concluded Mr. Boyd. 
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Image provided by Mr. Boyd 
HIV-1 Envelope (Env) interacts with the human CD4 
receptor to infect cells and establish infection (left panel). 
The CD4 proteins of most other species do not function 
as a receptor for HIV-1. The macaque CD4 protein can 
function as receptor for some strains of HIV-1, 
particularly for those adapted in culture, but not for HIV-1 
Envs from most globally circulating variants relevant to 
the HIV pandemic. The study of Boyd and colleagues 
suggests that mutations that allow HIV-1 Env to use the 
macaque CD4 receptor for entry induce conformational 
changes in Env that disrupt important epitopes 
(highlighted in magenta) that are currently the focus of 
HIV-1 vaccine design. 
 
